We revealed a novel anticancer mechanism that involves HBp17/FGFBP-1 function regulation by exosomal miR-6887-5p in SCC/OSCC cells, which has potential as a target for miRNA-based cancer therapy (Fig. 2). Here, FGFBP1 is linked to cancer.